Literature DB >> 9266882

Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital.

B Hirshberg1, I Biran, M Glazer, M R Kramer.   

Abstract

OBJECTIVES: Hemoptysis, an important and alarming symptom, often indicates serious disease. This study was designed to assess the different causes of hemoptysis, the relative importance of the different diagnostic modalities employed, and the outcome in an Israeli population cohort.
DESIGN: A retrospective analysis of 208 patients with hemoptysis at the Hadassah University Hospital, Jerusalem, Israel between January 1980 and August 1995.
RESULTS: Bronchiectasis (20%), lung cancer (19%), bronchitis (18%), and pneumonia (16%) accounted for most causes of hemoptysis. In contrast to older studies, active tuberculosis was a rare finding (1.4%). Bronchiectasis and bleeding diathesis were major causes of moderate to severe hemoptysis while bronchitis and lung cancer were commonly associated with milder degrees of bleeding. CT scan was the most sensitive diagnostic test when employed alone, with a positive yield of 67%. However, it failed to locate at least three cases of lung cancer. When combining a CT study together with a bronchoscopy, the positive yield increased to 93%. The mortality rate for patients with mild to moderate hemoptysis was low (2.5% and 6%, respectively), while patients with massive hemoptysis had high mortality rates (38%). Patients with lung cancer or bleeding diathesis had higher mortality rates compared with the rest of the cohort.
CONCLUSIONS: Hemoptysis is a common symptom with a good prognosis in most cases. However, patients exhibiting massive bleeding or those with lung malignancy and patients with bleeding diathesis had a poorer prognosis. Patients older than 50 years with a positive smoking history need an extensive evaluation and follow-up to exclude lung carcinoma. The combined use of bronchoscopy and chest CT has the best yield in evaluating hemoptysis.

Entities:  

Mesh:

Year:  1997        PMID: 9266882     DOI: 10.1378/chest.112.2.440

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  69 in total

1.  Bronchial artery embolization for hemoptysis.

Authors:  David R Sopko; Tony P Smith
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

2.  68-year-old man with chronic cough and weight loss.

Authors:  Megan M Dulohery; Furman S McDonald
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

3.  Covered bronchial stent insertion to manage airway obstruction with hemoptysis caused by lung cancer.

Authors:  Sae Ah Lee; Do Hyeong Kim; Gyeong Sik Jeon
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

4.  Massive cryptogenic hemoptysis undergoing pulmonary resection: clinical and pathological characteristics and management.

Authors:  Xiao-Dong Xia; Le-Ping Ye; Wei-Xi Zhang; Cheng-Yun Wu; Sun-Shun Yan; Hai-Xia Weng; Jie Lin; Hui Xu; Yue-Feng Zhang; Yuan-Rong Dai; Liang Dong
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Negative chest X-rays in primary care patients with lung cancer.

Authors:  Sally Stapley; Deborah Sharp; William Hamilton
Journal:  Br J Gen Pract       Date:  2006-08       Impact factor: 5.386

Review 6.  The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis.

Authors:  J L Lordan; A Gascoigne; P A Corris
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

7.  Bronchial artery embolization.

Authors:  Jonathan Lorenz; Deepa Sheth; Jay Patel
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

8.  Standardized Definitions of Bleeding After Transbronchial Lung Biopsy: A Delphi Consensus Statement From the Nashville Working Group.

Authors:  Erik E Folch; Amit K Mahajan; Catherine L Oberg; Fabien Maldonado; Eric Toloza; William S Krimsky; Scott Oh; Mark R Bowling; Sadia Benzaquen; Charles M Kinsey; Atul C Mehta; Sebastian Fernandez-Bussy; Javier Flandes; Kelvin Lau; Ganesh Krishna; Michael A Nead; Felix Herth; Alejandro A Aragaki-Nakahodo; Emanuela Barisione; Sandeep Bansal; Dragos Zanchi; Michael Zgoda; Peter O Lutz; Robert J Lentz; Christopher Parks; Mario Salio; Kenneth Perret; Colleen Keyes; Gregory P LeMense; John D Hinze; Adnan Majid; Merete Christensen; Jordan Kazakov; Gonzalo Labarca; Ernest Waller; Michael Studnicka; Catalina V Teba; Sandeep J Khandhar
Journal:  Chest       Date:  2020-02-14       Impact factor: 9.410

9.  Massive haemoptysis following dabigatran administration in a patient with bronchiectasis.

Authors:  Manabu Hayama; Hideki Inoue; Hiromichi Wada; Tadashi Mio
Journal:  BMJ Case Rep       Date:  2014-02-19

10.  Outcome and complications of bronchial artery embolisation for life-threatening haemoptysis.

Authors:  M M Slattery; A N Keeling; M J Lee
Journal:  Ir J Med Sci       Date:  2008-10-25       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.